Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Genomictree Inc.
No Price
Closing Price XKOS 29.04.2026:
17.660,00 KRW
29.04.2026 05:03
Current Prices from Genomictree Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
KOSDAQ
228760.KQ
KRW
29.04.2026 05:03
17.660,00 KRW
-90,00 KRW
-0,51 %
Share Float & Liquidity
Free Float83,10 %
Shares Float19,96 M
Shares Outstanding24,02 M
Company Profile for Genomictree Inc. Share
Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraTect-KRAS and AccuraTect-BRAF that are companion diagnostics for colorectal cancer; AccuraTect-EGFR, a companion diagnostic for lung cancer; and AccuraDTect SARS-CoV-2 RT-qPCR kits, as well as test providers. Genomictree Inc. was founded in 2000 and is headquartered in Daejeon, South Korea.
